Rankiteo Logo
Rankiteo
Leader in Cyber Underwriting
Loading...
NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop
WindowsmacOSLinux
Download

Comparison Overview

Qorvo BiotechnologiesQorvo Biotechnologies
VS
ICON plcICON plc
Qorvo Biotechnologies

Qorvo Biotechnologies

N/A

Last Update: 03/04/2026

View Profile
Between 700 and 749
https://www.qorvo.com/innovation/biotechnologies
749/1000Moderate

Qorvo Biotechnologies, LLC is a wholly owned subsidiary of Qorvo, Inc. focused on developing point-of-care (POC) diagnostics solutions leveraging Qorvo’s innovative BAW sensor technology.

NAICS:541714
NAICS Definition:Research and Development in Biotechnology (except Nanobiotechnology)
Employees:19
Subsidiaries:5
12-month incidents
0
Known data breaches
0
Attack type number
0
ICON plc

ICON plc

ICON plc, South County Business Park, Leopardstown, Dublin, IE, D18 X5R3

Last Update: 02/04/2026

View Profile
Between 750 and 799
http://www.iconplc.com
796/1000Fair

Since our foundation in Dublin, Ireland in 1990, our mission has been to help our clients to accelerate the development of drugs and devices that save lives and improve quality of life. We do this by delivering best in class information, solutions and performance, with ...

NAICS:541714
NAICS Definition:Research and Development in Biotechnology (except Nanobiotechnology)
Employees:34,531
Subsidiaries:9
12-month incidents
0
Known data breaches
0
Attack type number
0

Compliance Ranges Comparison

Based On Specific Ai Models Category
Qorvo Biotechnologies

Qorvo Biotechnologies

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA
ICON plc

ICON plc

-
ISO 27001Not verified
ISO 27001
-
SOC2 Type 1Not verified
SOC2 Type 1
-
SOC2 Type 2Not verified
SOC2 Type 2
-
GDPRNot verified
GDPR
-
PCI DSSNot verified
PCI DSS
-
HIPAANot verified
HIPAA

Benchmark & Cyber Underwriting Signals

Incidents vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Qorvo Biotechnologies in 2026.

Incidents

Incidents vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for ICON plc in 2026.

Incidents

Incident History - Qorvo Biotechnologies (X = Date, Y = Severity)

Qorvo Biotechnologies cyber incidents detection timeline including parent company and subsidiaries.

R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Incident History - ICON plc (X = Date, Y = Severity)

ICON plc cyber incidents detection timeline including parent company and subsidiaries.

No timeline data available
R - Ransomware
C - Cyber Attack
D - Data Breach
V - Vulnerability

Notable Incidents

Last Cyber / HR Incidents / Global...
Qorvo Biotechnologies

Qorvo Biotechnologies

Incidents
No explicit notable incidents reported.
ICON plc

ICON plc

Incidents
No explicit notable incidents reported.

FAQ

Between Qorvo Biotechnologies company and ICON plc company, which one has the best AI Cybersecurity Score ?
Between Qorvo Biotechnologies company and ICON plc company, which one has experienced more cyber incidents in the past ?
Between Qorvo Biotechnologies company and ICON plc company, which one has experienced more cyber incidents this year ?
Between Qorvo Biotechnologies company and ICON plc company, which one has experienced at least one ransomware attack ?
Between Qorvo Biotechnologies company and ICON plc company, which one has experienced at least one data breach ?
Between Qorvo Biotechnologies company and ICON plc company, which one has experienced at least one targeted cyberattack ?
Between Qorvo Biotechnologies company and ICON plc company, which one has experienced at least one vulnerability ?
Between Qorvo Biotechnologies company and ICON plc company, which one holds the most compliance certifications ?
Between Qorvo Biotechnologies company and ICON plc company, which one holds the fewest compliance certifications ?
Between Qorvo Biotechnologies company and ICON plc company, which one has the most subsidiaries ?
Between Qorvo Biotechnologies company and ICON plc company, which one has the largest number of employees ?
Between Qorvo Biotechnologies and ICON plc, which company holds both SOC 2 Type 1 certifications ?
Between Qorvo Biotechnologies and ICON plc, which company holds both SOC 2 Type 2 certifications ?
Which company is ISO 27001 certified - Qorvo Biotechnologies or ICON plc ?
Which company is PCI DSS compliant - Qorvo Biotechnologies or ICON plc ?
Between Qorvo Biotechnologies and ICON plc, which company complies with HIPAA regulations for healthcare data ?
Between Qorvo Biotechnologies and ICON plc, which company complies with GDPR requirements ?

Latest Global CVEs

CVE-2026-57100
SUMMARY

Server-side request forgery (ssrf) in Microsoft Entra Provisioning Service (SyncFabric) allows an authorized attacker to elevate privileges over a network.

PUBLISHED
Date2026-07-02
UPDATED
Date2026-07-02
RISK INFORMATION (Score: 9.9)
CVSS3
Base Score: 9.9
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:H
IMPACT SCORE
6
EXPLOITABILITY
3.1
REFERENCES
CVE-2026-54998
SUMMARY

Incorrect authorization in Microsoft Exchange Online allows an authorized attacker to elevate privileges over a network.

PUBLISHED
Date2026-07-02
UPDATED
Date2026-07-02
RISK INFORMATION (Score: 8.8)
CVSS3
Base Score: 8.8
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
IMPACT SCORE
5.9
EXPLOITABILITY
2.8
REFERENCES
CVE-2026-45499
SUMMARY

Server-side request forgery (ssrf) in Azure OpenAI allows an authorized attacker to elevate privileges over a network.

PUBLISHED
Date2026-07-02
UPDATED
Date2026-07-02
RISK INFORMATION (Score: 9.9)
CVSS3
Base Score: 9.9
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:H
IMPACT SCORE
6
EXPLOITABILITY
3.1
REFERENCES
CVE-2026-41106
SUMMARY

Url redirection to untrusted site ('open redirect') in M365 Copilot allows an unauthorized attacker to elevate privileges over a network.

PUBLISHED
Date2026-07-02
UPDATED
Date2026-07-02
RISK INFORMATION (Score: 9.3)
CVSS3
Base Score: 9.3
Complexity: LOW
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:H/I:H/A:N
IMPACT SCORE
5.8
EXPLOITABILITY
2.8
REFERENCES
CVE-2026-26145
SUMMARY

Improper access control in Azure Synapse allows an authorized attacker to elevate privileges over a network.

PUBLISHED
Date2026-07-02
UPDATED
Date2026-07-02
RISK INFORMATION (Score: 4.8)
CVSS3
Base Score: 4.8
Complexity: HIGH
CVSS:3.1/AV:N/AC:H/PR:L/UI:R/S:U/C:H/I:N/A:N
IMPACT SCORE
3.6
EXPLOITABILITY
1.2
REFERENCES